Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Zafirlukast

2

X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

2
Last update : 22/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Montelukast
2
Pranlukast
2

Publications

Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.
Seminars in respiratory and critical care medicine 2011 Jun;32;298-309 2011 Jun
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?
Drug safety 1999 Oct;21;241-51 1999 Oct
Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment.
Lancet (London, England) 1999 Feb 27;353;725-6 1999 Feb 27
Churg-Strauss syndrome associated with zafirlukast.
The Journal of the American Osteopathic Association 1998 May;98;275-8 1998 May
Churg-Strauss syndrome associated with zafirlukast.
Chest 1998 Jul;114;332-4 1998 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies